Using a novel method, Weizmann Institute researchers map 16 types of simultaneous changes in dozens of samples; findings can ...

All starting from the same DNA, neurons ultimately take on individual characteristics in the brain and body. Differences in which genes they ...

TheFly reported on December  16 that Oppenheimer raised its price target on WVE to $32 from $24 while maintaining an ...

For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Scientists identify the first non-coding gene that directly controls cell size, reshaping how biology explains growth and ...

Study finds middle age changes how brains respond to weight loss. Brain inflammation increased during dieting despite ...